SAS2

Summary: SAS2 is the catalytic component of the SAS complex which acetylates H4K16 of free histones. This IBA annotation reflects phylogenetic inference and is mechanistically accurate for the specific substrate. The SAS complex specifically acetylates both H4K16 and H3K14, making this a core molecular function.

Reason: UniProt explicitly states SAS2 as catalytic subunit acetylates Lys-16 of histone H4. PMID:12626510 confirms the recombinant and native SAS complex acetylates H4 lysine 16 with high specificity. IBA inference is appropriate for this well-characterized enzymatic activity.

Summary: SAS2 acetylates lysine 14 of histone H3 as a substrate-specific molecular function. PMID:12626510 provides direct biochemical evidence that the SAS complex acetylates both H4 lysine 16 AND H3 lysine 14 with equal specificity and importance. This is equally well-documented as the H4K16 activity but was missing from the annotation set.

Reason: UniProt functional description states SAS2 acetylates "Lys-16 of histone H4 and Lys-14 of histone H3". PMID:12626510 provides direct evidence: "The recombinant SAS complex acetylates H4 lysine 16 and H3 lysine 14. Furthermore, a purified SAS complex from yeast shows similar activity and specificity." This substrate-specific function is documented with the same strength as GO:0046972 (H4K16) and should be included as a core molecular function. Note: the falcon deep research report flagged that, within its retrieved excerpts, H4K16 was the only robustly supported in vivo substrate and additional substrates "should not be asserted without direct evidence." This does not contradict the H3K14 annotation, which rests on the direct in vitro biochemistry of PMID:12626510; it does, however, indicate H3K14 acetylation is less prominent in the in vivo chromatin literature than H4K16, so it is retained as NEW rather than promoted above the H4K16 activity.

Summary: SAS2 is annotated as part of NuA4 HAT complex by IBA. However, UniProt and primary literature clearly state SAS2 is part of the SAS complex (with SAS4 and SAS5), not NuA4. NuA4 is a different HAT complex with distinct subunits and functions. This is an incorrect phylogenetic inference.

Reason: SAS2 is definitively a component of the SAS acetyltransferase complex, not NuA4. UniProt CC field: "Component of the SAS complex, at least composed of SAS2, SAS4 and SAS5". GO:0033255 SAS acetyltransferase complex is the correct complex annotation for this gene. IBA inference incorrectly assigned SAS2 to NuA4.

Summary: SAS2 is involved in transcriptional silencing at telomeres and subtelomeres, making localization to telomeric regions biologically relevant. However, this is inferred from GO:0031509 (subtelomeric heterochromatin formation) via IEA logical inference. The annotation is supported by functional evidence of SAS2 involvement in telomeric silencing.

Reason: While SAS2 is functional at telomeric and subtelomeric regions, the primary molecular function is histone acetyltransferase activity and the biological process is silencing/heterochromatin formation. Chromosomal localization is secondary and could be misleading without context. The IEA inference is logically sound but the term is too broad (chromosome, telomeric region encompasses many genes without specific roles there).

Summary: SAS2 possesses histone acetyltransferase activity as its primary biochemical function. The IEA annotation via InterPro and RHEA is appropriate for this conserved domain function, representing the general HAT activity class.

Reason: GO:0004402 (histone acetyltransferase activity) is a general term that encompasses SAS2s specific H4K16 and H3K14 acetylation activities. The IEA is supported by InterPro domain mapping and direct enzymatic characterization. This is appropriate as a parent term to the more specific H4K16 acetyltransferase function.

Summary: SAS2 is localized to the nucleus based on UniProt subcellular location annotation, consistent with its function in chromatin regulation. This IEA from UniProtKB subcellular location is reliable.

Reason: SAS2 is documented as localized to nucleus and cytoplasm per UniProt (ECO:0000269|PubMed:14562095). The nucleus annotation is appropriate and supported by experimental evidence. IEA is justified for this standard cellular compartment annotation.

Summary: SAS2 is localized to both nucleus and cytoplasm according to UniProt. The cytoplasmic localization may reflect either protein processing or a minor cytoplasmic pool, but the primary functional compartment is nuclear.

Reason: UniProt documents both nucleus and cytoplasm localization with evidence from PMID:14562095 (large-scale localization study), so the annotation is retained rather than removed. However, the falcon deep research synthesis consistently characterizes Sas2 as a chromatin-bound nuclear protein (nucleus including the nucleolus, with ChIP association to rDNA) and provides no evidence for a functional cytoplasmic role. The cytoplasmic pool is therefore demoted to non-core: SAS2 executes its histone acetyltransferase function exclusively in the nucleus on chromatin.

Summary: SAS2 participates in chromatin organization through its HAT activity, affecting histone modifications and chromatin structure. The IEA from UniProtKB keywords (chromatin regulator) appropriately captures this functional role.

Reason: SAS2 is a chromatin regulator involved in histone acetylation and chromatin assembly/remodeling. GO:0006325 chromatin organization is an appropriate biological process annotation reflecting the downstream effects of HAT activity. IEA inference from keywords is justified.

Summary: SAS2 indirectly affects transcription through chromatin modifications, but the primary function is histone modification at specific loci (silencing at telomeres, HML). The IEA from keywords likely reflects the broad but indirect transcriptional effects of HAT activity.

Reason: While SAS2 affects chromatin state and can indirectly influence transcription, the specific functional role is transcriptional silencing at telomeres/subtelomeres, not general transcription. GO:0006351 is too general and suggests a broader transcriptional role than what is known. Transcriptional regulation (GO:0006355) is more mechanistically accurate than the process of transcription itself.

Summary: SAS2 regulates transcription by acetylating histones at silenced loci (telomeres, HML), repressing transcription in those regions while potentially permitting transcription elsewhere. GO:0006355 appropriately captures this regulatory role without implying general transcriptional activation.

Reason: SAS2 regulates transcription through histone acetylation-mediated chromatin organization. The GO:0006355 term is appropriately intermediate between general transcription (GO:0006351) and specific processes (silencing). IBA/IEA inference from HAT domain function is justified.

Summary: SAS2 contains a MYST-type HAT domain with a C2HC zinc-finger motif essential for catalytic activity. Zinc binding is a structural requirement for HAT activity, documented in UniProt features.

Reason: UniProt documents zinc finger structure: "ZN_FING 100..126: C2HC MYST-type". Zinc coordination is essential for the catalytic mechanism of MYST-family acetyltransferases. IEA from zinc keyword is supported by structural annotations.

Summary: This is a very broad parent term encompassing the effects of histone acetylation on gene expression regulation. While technically correct, it is less specific than the actual biological processes SAS2 participates in.

Reason: GO:0010468 is overly broad and abstract. SAS2s known roles are more specifically: (1) subtelomeric heterochromatin formation (GO:0031509), (2) silent mating-type cassette heterochromatin formation (GO:0030466), and (3) transcription regulation via histone modification. The more specific terms (GO:0031509, GO:0030466) should be preferred.

Summary: SAS2 catalyzes acetyl group transfer from acetyl-CoA to lysine residues on histones. GO:0016740 transferase activity is the parent term for all acetyltransferase activities.

Reason: GO:0016740 is a valid parent term for SAS2s acetyltransferase functions. The specificity hierarchy is appropriate: transferase activity (GO:0016740) > acetyltransferase activity (GO:0016407) > protein-lysine-acetyltransferase activity (GO:0061733) > histone acetyltransferase activity (GO:0004402) > H4K16 acetyltransferase activity (GO:0046972).

Summary: Acetyltransferases are a subset of acyltransferases that transfer the acetyl group (an acyl group) from acetyl-CoA. This is a parent term that appropriately classifies the enzyme.

Reason: GO:0016746 (acyltransferase activity) is a valid parent term that correctly classifies SAS2. The hierarchy is: acyltransferase activity (GO:0016746) > acetyltransferase activity (GO:0016407). IEA is justified for this biochemical classification.

Summary: SAS2 binds zinc ions as an essential cofactor for catalytic function. GO:0046872 is the parent term for all metal ion binding activities including zinc binding.

Reason: Metal ion binding (specifically zinc) is documented in UniProt features and is essential for SAS2 HAT activity. GO:0046872 is an appropriate parent term with GO:0008270 (zinc ion binding) as the more specific child term.

Summary: SAS2 catalyzes the transfer of acetyl groups from acetyl-CoA to lysine residues on protein substrates (histones). This is the direct enzymatic activity captured by GO:0061733.

Reason: GO:0061733 is mechanistically accurate for SAS2s enzymatic function. UniProt documents EC number 2.3.1.48 (protein-lysine-acetyltransferase), and PMID:12626510 demonstrates lysine acetylation. This term is more specific than general transferase activity but broader than histone-specific acetyltransferases.

Summary: SAS2 interacts with SAS4, SAS5, ASF1, and other chromatin factors. However, generic protein binding is not informative and masks the specific functional interactions (complex assembly, substrate presentation, etc.).

Reason: GO:0005515 (protein binding) is a vague annotation that provides minimal functional information. The underlying IPI data references protein-protein interactions identified in biochemical purifications and mass spectrometry. More informative would be direct component annotations of specific protein complexes (GO:0033255 SAS acetyltransferase complex). Individual protein binding events should not be annotated to the generic protein binding term.

Summary: Generic protein binding annotation from global protein complex inventory.

Reason: These IPI annotations from PMID:16554755 (BioGRID protein complex survey) and others identify SAS2 component membership in the SAS complex, which is better captured by GO:0033255 than by vague protein binding annotations.

Summary: Generic protein binding annotation from chromatin-associated interactome data.

Reason: The IPI evidence documents SAS2 as component of chromatin-associated complexes. Complex membership is better represented by GO:0033255 than generic protein binding.

Summary: Generic protein binding from protein interactome study.

Reason: Vague protein binding annotation. Remove in favor of specific complex membership annotations (GO:0033255).

Summary: SAS2 contains zinc-coordinating cysteine residues in its MYST-type HAT domain, documented as essential for catalytic activity. The RCA evidence from zinc proteome characterization confirms the zinc coordination.

Reason: Zinc binding is established in SAS2 through MYST-type HAT domain with C2HC zinc-finger motif. PMID:30358795 (Zinc proteome) provides direct biochemical evidence via RCA (Reviewed Computational Analysis). This annotation is well-supported.

Summary: SAS2 is experimentally demonstrated to be required for transcriptional silencing and heterochromatin formation at subtelomeric regions and HML locus. This IDA is mechanistically well-characterized and represents a core function of SAS2.

Reason: PMID:11731479 demonstrates SAS2 function with chromatin assembly factor ASF1 in silencing. The role in subtelomeric heterochromatin formation is well-established. IDA is appropriate evidence code for this experimentally characterized process.

Summary: SAS2 localizes to and functions within chromatin as part of histone acetylation complexes. The chromatin component annotation reflects the cellular compartment where SAS2 executes its function.

Reason: SAS2 is a chromatin-associated protein that modifies histones. The GO:0000785 (chromatin) annotation is appropriate for a histone acetyltransferase. IDA evidence from chromatin purifications/characterizations is justified.

Summary: SAS2 is shown through mutant/deletion studies to be involved in maintaining transcriptional silencing at the silent mating-type locus (HML). This IMP evidence characterizes a specific SAS2 function in heterochromatin establishment/maintenance.

Reason: SAS2 participates in heterochromatin formation at silent mating-type loci. PMID:27655944 provides IMP evidence from genetic studies. UniProt also documents: "Involved in transcriptional silencing at telomeres and at HML locus". This is a well-supported biological process.

Summary: Direct biochemical demonstration of SAS2 HAT activity through in vitro acetyltransferase assays with purified recombinant and native SAS complex. This IDA evidence is strong and mechanistic.

Reason: PMID:12626510 provides direct experimental evidence of HAT activity through enzyme assay of purified SAS complex containing SAS2. This is the gold standard IDA evidence. The annotation is accurate and well-supported.

Summary: SAS2 is demonstrated to have acetyltransferase activity through biochemical characterization. GO:0016407 is the parent term for histone acetyltransferase activity, appropriately classifying SAS2s enzymatic function.

Reason: Acetyltransferase activity is well-established for SAS2. IDA from PMID:11731479 (purification and characterization of SAS complex with Sas2 as MYST-type acetyltransferase) provides direct evidence. This is an appropriate parent term.

Summary: SAS2 is the catalytic core of the SAS acetyltransferase complex, composed minimally of SAS2, SAS4, and SAS5. IDA evidence from complex purification and functional assays directly demonstrates SAS2 component membership.

Reason: SAS2 is a core component of the SAS complex, definitively established through biochemistry. PMID:12626510 characterizes the complex composition and function. GO:0033255 is the appropriate term for this complex, and SAS2 must be annotated as part_of this complex.

Summary: SAS2 nuclear import associated with complex assembly documented by IPI evidence from interaction studies.

Reason: PMID:15788653 documents nuclear import of the SAS-I complex (SAS complex), providing complementary IPI evidence of SAS2 participation. Multiple independent lines of evidence (IDA and IPI) support SAS2 as component of GO:0033255.